ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemophilia A Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-15M9525
Home | Market Reports | Health| Health Conditions
Global Hemophilia A Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Global Hemophilia A Drug Market Research Report 2025

Code: QYRE-Auto-15M9525
Report
September 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
BioMarin Pharmaceutical Inc
Bioverativ
Catalyst Biosciences Inc
Chugai Pharmaceutical Co., Ltd.
CSL Limited
DBV Technologies SA
Dimension Therapeutics Inc
EpiVax
Expression Therapeutics LLC
Green Cross Corp
Idogen AB
Immusoft Corp
LFB SA
mAbxience SA

Hemophilia A Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Hemophilia A Drug Market

Hemophilia A Drug Market

The global market for Hemophilia A Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hemophilia A Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemophilia A Drug.
The Hemophilia A Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemophilia A Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemophilia A Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hemophilia A Drug Market Report

Report Metric Details
Report Name Hemophilia A Drug Market
CAGR 5%
Segment by Type
  • ATXF-8117
  • BAY-1093884
  • BIVV-001
  • BS-027125
  • Concizumab
  • CSL-689
  • Others
Segment by Application
  • Clinic
  • Hospital
  • ASCs
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer AG, BioMarin Pharmaceutical Inc, Bioverativ Inc, Catalyst Biosciences Inc, Chugai Pharmaceutical Co Ltd, CSL Ltd, DBV Technologies SA, Dimension Therapeutics Inc, EpiVax Inc, Expression Therapeutics LLC, Green Cross Corp, Idogen AB, Immusoft Corp, LFB SA, mAbxience SA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hemophilia A Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hemophilia A Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Hemophilia A Drug Market report?

Ans: The main players in the Hemophilia A Drug Market are Bayer AG, BioMarin Pharmaceutical Inc, Bioverativ Inc, Catalyst Biosciences Inc, Chugai Pharmaceutical Co Ltd, CSL Ltd, DBV Technologies SA, Dimension Therapeutics Inc, EpiVax Inc, Expression Therapeutics LLC, Green Cross Corp, Idogen AB, Immusoft Corp, LFB SA, mAbxience SA

What are the Application segmentation covered in the Hemophilia A Drug Market report?

Ans: The Applications covered in the Hemophilia A Drug Market report are Clinic, Hospital, ASCs

What are the Type segmentation covered in the Hemophilia A Drug Market report?

Ans: The Types covered in the Hemophilia A Drug Market report are ATXF-8117, BAY-1093884, BIVV-001, BS-027125, Concizumab, CSL-689, Others

Recommended Reports

Blood Disorder Drugs

Pharmaceutical Testing

Chronic Disease Drugs

1 Hemophilia A Drug Market Overview
1.1 Product Definition
1.2 Hemophilia A Drug by Type
1.2.1 Global Hemophilia A Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 ATXF-8117
1.2.3 BAY-1093884
1.2.4 BIVV-001
1.2.5 BS-027125
1.2.6 Concizumab
1.2.7 CSL-689
1.2.8 Others
1.3 Hemophilia A Drug by Application
1.3.1 Global Hemophilia A Drug Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 ASCs
1.4 Global Hemophilia A Drug Market Size Estimates and Forecasts
1.4.1 Global Hemophilia A Drug Revenue 2020-2031
1.4.2 Global Hemophilia A Drug Sales 2020-2031
1.4.3 Global Hemophilia A Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hemophilia A Drug Market Competition by Manufacturers
2.1 Global Hemophilia A Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hemophilia A Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hemophilia A Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hemophilia A Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemophilia A Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemophilia A Drug, Product Type & Application
2.7 Global Key Manufacturers of Hemophilia A Drug, Date of Enter into This Industry
2.8 Global Hemophilia A Drug Market Competitive Situation and Trends
2.8.1 Global Hemophilia A Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hemophilia A Drug Players Market Share by Revenue
2.8.3 Global Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemophilia A Drug Market Scenario by Region
3.1 Global Hemophilia A Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hemophilia A Drug Sales by Region: 2020-2031
3.2.1 Global Hemophilia A Drug Sales by Region: 2020-2025
3.2.2 Global Hemophilia A Drug Sales by Region: 2026-2031
3.3 Global Hemophilia A Drug Revenue by Region: 2020-2031
3.3.1 Global Hemophilia A Drug Revenue by Region: 2020-2025
3.3.2 Global Hemophilia A Drug Revenue by Region: 2026-2031
3.4 North America Hemophilia A Drug Market Facts & Figures by Country
3.4.1 North America Hemophilia A Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hemophilia A Drug Sales by Country (2020-2031)
3.4.3 North America Hemophilia A Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemophilia A Drug Market Facts & Figures by Country
3.5.1 Europe Hemophilia A Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hemophilia A Drug Sales by Country (2020-2031)
3.5.3 Europe Hemophilia A Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemophilia A Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Hemophilia A Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hemophilia A Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Hemophilia A Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hemophilia A Drug Market Facts & Figures by Country
3.7.1 Latin America Hemophilia A Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hemophilia A Drug Sales by Country (2020-2031)
3.7.3 Latin America Hemophilia A Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemophilia A Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemophilia A Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hemophilia A Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hemophilia A Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemophilia A Drug Sales by Type (2020-2031)
4.1.1 Global Hemophilia A Drug Sales by Type (2020-2025)
4.1.2 Global Hemophilia A Drug Sales by Type (2026-2031)
4.1.3 Global Hemophilia A Drug Sales Market Share by Type (2020-2031)
4.2 Global Hemophilia A Drug Revenue by Type (2020-2031)
4.2.1 Global Hemophilia A Drug Revenue by Type (2020-2025)
4.2.2 Global Hemophilia A Drug Revenue by Type (2026-2031)
4.2.3 Global Hemophilia A Drug Revenue Market Share by Type (2020-2031)
4.3 Global Hemophilia A Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hemophilia A Drug Sales by Application (2020-2031)
5.1.1 Global Hemophilia A Drug Sales by Application (2020-2025)
5.1.2 Global Hemophilia A Drug Sales by Application (2026-2031)
5.1.3 Global Hemophilia A Drug Sales Market Share by Application (2020-2031)
5.2 Global Hemophilia A Drug Revenue by Application (2020-2031)
5.2.1 Global Hemophilia A Drug Revenue by Application (2020-2025)
5.2.2 Global Hemophilia A Drug Revenue by Application (2026-2031)
5.2.3 Global Hemophilia A Drug Revenue Market Share by Application (2020-2031)
5.3 Global Hemophilia A Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Company Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer AG Hemophilia A Drug Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 BioMarin Pharmaceutical Inc
6.2.1 BioMarin Pharmaceutical Inc Company Information
6.2.2 BioMarin Pharmaceutical Inc Description and Business Overview
6.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioMarin Pharmaceutical Inc Hemophilia A Drug Product Portfolio
6.2.5 BioMarin Pharmaceutical Inc Recent Developments/Updates
6.3 Bioverativ Inc
6.3.1 Bioverativ Inc Company Information
6.3.2 Bioverativ Inc Description and Business Overview
6.3.3 Bioverativ Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bioverativ Inc Hemophilia A Drug Product Portfolio
6.3.5 Bioverativ Inc Recent Developments/Updates
6.4 Catalyst Biosciences Inc
6.4.1 Catalyst Biosciences Inc Company Information
6.4.2 Catalyst Biosciences Inc Description and Business Overview
6.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Catalyst Biosciences Inc Hemophilia A Drug Product Portfolio
6.4.5 Catalyst Biosciences Inc Recent Developments/Updates
6.5 Chugai Pharmaceutical Co Ltd
6.5.1 Chugai Pharmaceutical Co Ltd Company Information
6.5.2 Chugai Pharmaceutical Co Ltd Description and Business Overview
6.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Portfolio
6.5.5 Chugai Pharmaceutical Co Ltd Recent Developments/Updates
6.6 CSL Ltd
6.6.1 CSL Ltd Company Information
6.6.2 CSL Ltd Description and Business Overview
6.6.3 CSL Ltd Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSL Ltd Hemophilia A Drug Product Portfolio
6.6.5 CSL Ltd Recent Developments/Updates
6.7 DBV Technologies SA
6.7.1 DBV Technologies SA Company Information
6.7.2 DBV Technologies SA Description and Business Overview
6.7.3 DBV Technologies SA Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 DBV Technologies SA Hemophilia A Drug Product Portfolio
6.7.5 DBV Technologies SA Recent Developments/Updates
6.8 Dimension Therapeutics Inc
6.8.1 Dimension Therapeutics Inc Company Information
6.8.2 Dimension Therapeutics Inc Description and Business Overview
6.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Dimension Therapeutics Inc Hemophilia A Drug Product Portfolio
6.8.5 Dimension Therapeutics Inc Recent Developments/Updates
6.9 EpiVax Inc
6.9.1 EpiVax Inc Company Information
6.9.2 EpiVax Inc Description and Business Overview
6.9.3 EpiVax Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 EpiVax Inc Hemophilia A Drug Product Portfolio
6.9.5 EpiVax Inc Recent Developments/Updates
6.10 Expression Therapeutics LLC
6.10.1 Expression Therapeutics LLC Company Information
6.10.2 Expression Therapeutics LLC Description and Business Overview
6.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Expression Therapeutics LLC Hemophilia A Drug Product Portfolio
6.10.5 Expression Therapeutics LLC Recent Developments/Updates
6.11 Green Cross Corp
6.11.1 Green Cross Corp Company Information
6.11.2 Green Cross Corp Description and Business Overview
6.11.3 Green Cross Corp Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Green Cross Corp Hemophilia A Drug Product Portfolio
6.11.5 Green Cross Corp Recent Developments/Updates
6.12 Idogen AB
6.12.1 Idogen AB Company Information
6.12.2 Idogen AB Description and Business Overview
6.12.3 Idogen AB Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Idogen AB Hemophilia A Drug Product Portfolio
6.12.5 Idogen AB Recent Developments/Updates
6.13 Immusoft Corp
6.13.1 Immusoft Corp Company Information
6.13.2 Immusoft Corp Description and Business Overview
6.13.3 Immusoft Corp Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Immusoft Corp Hemophilia A Drug Product Portfolio
6.13.5 Immusoft Corp Recent Developments/Updates
6.14 LFB SA
6.14.1 LFB SA Company Information
6.14.2 LFB SA Description and Business Overview
6.14.3 LFB SA Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.14.4 LFB SA Hemophilia A Drug Product Portfolio
6.14.5 LFB SA Recent Developments/Updates
6.15 mAbxience SA
6.15.1 mAbxience SA Company Information
6.15.2 mAbxience SA Description and Business Overview
6.15.3 mAbxience SA Hemophilia A Drug Sales, Revenue and Gross Margin (2020-2025)
6.15.4 mAbxience SA Hemophilia A Drug Product Portfolio
6.15.5 mAbxience SA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemophilia A Drug Industry Chain Analysis
7.2 Hemophilia A Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemophilia A Drug Production Mode & Process Analysis
7.4 Hemophilia A Drug Sales and Marketing
7.4.1 Hemophilia A Drug Sales Channels
7.4.2 Hemophilia A Drug Distributors
7.5 Hemophilia A Drug Customer Analysis
8 Hemophilia A Drug Market Dynamics
8.1 Hemophilia A Drug Industry Trends
8.2 Hemophilia A Drug Market Drivers
8.3 Hemophilia A Drug Market Challenges
8.4 Hemophilia A Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
BioMarin Pharmaceutical Inc
Bioverativ
Catalyst Biosciences Inc
Chugai Pharmaceutical Co., Ltd.
CSL Limited
DBV Technologies SA
Dimension Therapeutics Inc
EpiVax
Expression Therapeutics LLC
Green Cross Corp
Idogen AB
Immusoft Corp
LFB SA
mAbxience SA
List of Tables
 Table 1. Global Hemophilia A Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hemophilia A Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hemophilia A Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hemophilia A Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Hemophilia A Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hemophilia A Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hemophilia A Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hemophilia A Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hemophilia A Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hemophilia A Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hemophilia A Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Hemophilia A Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hemophilia A Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia A Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hemophilia A Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hemophilia A Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Hemophilia A Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Hemophilia A Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Hemophilia A Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Hemophilia A Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hemophilia A Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Hemophilia A Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hemophilia A Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Hemophilia A Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hemophilia A Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Hemophilia A Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Hemophilia A Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hemophilia A Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hemophilia A Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hemophilia A Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Hemophilia A Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Hemophilia A Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hemophilia A Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hemophilia A Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hemophilia A Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Hemophilia A Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Hemophilia A Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hemophilia A Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hemophilia A Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hemophilia A Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Hemophilia A Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Hemophilia A Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hemophilia A Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hemophilia A Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hemophilia A Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Hemophilia A Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Hemophilia A Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hemophilia A Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hemophilia A Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Hemophilia A Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Hemophilia A Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Hemophilia A Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Hemophilia A Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hemophilia A Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hemophilia A Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Hemophilia A Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Hemophilia A Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Hemophilia A Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Hemophilia A Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Hemophilia A Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Hemophilia A Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Hemophilia A Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Hemophilia A Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hemophilia A Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hemophilia A Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Hemophilia A Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Hemophilia A Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Hemophilia A Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Bayer AG Company Information
 Table 71. Bayer AG Description and Business Overview
 Table 72. Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Bayer AG Hemophilia A Drug Product
 Table 74. Bayer AG Recent Developments/Updates
 Table 75. BioMarin Pharmaceutical Inc Company Information
 Table 76. BioMarin Pharmaceutical Inc Description and Business Overview
 Table 77. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. BioMarin Pharmaceutical Inc Hemophilia A Drug Product
 Table 79. BioMarin Pharmaceutical Inc Recent Developments/Updates
 Table 80. Bioverativ Inc Company Information
 Table 81. Bioverativ Inc Description and Business Overview
 Table 82. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Bioverativ Inc Hemophilia A Drug Product
 Table 84. Bioverativ Inc Recent Developments/Updates
 Table 85. Catalyst Biosciences Inc Company Information
 Table 86. Catalyst Biosciences Inc Description and Business Overview
 Table 87. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Catalyst Biosciences Inc Hemophilia A Drug Product
 Table 89. Catalyst Biosciences Inc Recent Developments/Updates
 Table 90. Chugai Pharmaceutical Co Ltd Company Information
 Table 91. Chugai Pharmaceutical Co Ltd Description and Business Overview
 Table 92. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product
 Table 94. Chugai Pharmaceutical Co Ltd Recent Developments/Updates
 Table 95. CSL Ltd Company Information
 Table 96. CSL Ltd Description and Business Overview
 Table 97. CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. CSL Ltd Hemophilia A Drug Product
 Table 99. CSL Ltd Recent Developments/Updates
 Table 100. DBV Technologies SA Company Information
 Table 101. DBV Technologies SA Description and Business Overview
 Table 102. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. DBV Technologies SA Hemophilia A Drug Product
 Table 104. DBV Technologies SA Recent Developments/Updates
 Table 105. Dimension Therapeutics Inc Company Information
 Table 106. Dimension Therapeutics Inc Description and Business Overview
 Table 107. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Dimension Therapeutics Inc Hemophilia A Drug Product
 Table 109. Dimension Therapeutics Inc Recent Developments/Updates
 Table 110. EpiVax Inc Company Information
 Table 111. EpiVax Inc Description and Business Overview
 Table 112. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. EpiVax Inc Hemophilia A Drug Product
 Table 114. EpiVax Inc Recent Developments/Updates
 Table 115. Expression Therapeutics LLC Company Information
 Table 116. Expression Therapeutics LLC Description and Business Overview
 Table 117. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Expression Therapeutics LLC Hemophilia A Drug Product
 Table 119. Expression Therapeutics LLC Recent Developments/Updates
 Table 120. Green Cross Corp Company Information
 Table 121. Green Cross Corp Description and Business Overview
 Table 122. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Green Cross Corp Hemophilia A Drug Product
 Table 124. Green Cross Corp Recent Developments/Updates
 Table 125. Idogen AB Company Information
 Table 126. Idogen AB Description and Business Overview
 Table 127. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Idogen AB Hemophilia A Drug Product
 Table 129. Idogen AB Recent Developments/Updates
 Table 130. Immusoft Corp Company Information
 Table 131. Immusoft Corp Description and Business Overview
 Table 132. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Immusoft Corp Hemophilia A Drug Product
 Table 134. Immusoft Corp Recent Developments/Updates
 Table 135. LFB SA Company Information
 Table 136. LFB SA Description and Business Overview
 Table 137. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. LFB SA Hemophilia A Drug Product
 Table 139. LFB SA Recent Developments/Updates
 Table 140. mAbxience SA Company Information
 Table 141. mAbxience SA Description and Business Overview
 Table 142. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. mAbxience SA Hemophilia A Drug Product
 Table 144. mAbxience SA Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Hemophilia A Drug Distributors List
 Table 148. Hemophilia A Drug Customers List
 Table 149. Hemophilia A Drug Market Trends
 Table 150. Hemophilia A Drug Market Drivers
 Table 151. Hemophilia A Drug Market Challenges
 Table 152. Hemophilia A Drug Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hemophilia A Drug
 Figure 2. Global Hemophilia A Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hemophilia A Drug Market Share by Type: 2024 & 2031
 Figure 4. ATXF-8117 Product Picture
 Figure 5. BAY-1093884 Product Picture
 Figure 6. BIVV-001 Product Picture
 Figure 7. BS-027125 Product Picture
 Figure 8. Concizumab Product Picture
 Figure 9. CSL-689 Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Hemophilia A Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Hemophilia A Drug Market Share by Application: 2024 & 2031
 Figure 13. Clinic
 Figure 14. Hospital
 Figure 15. ASCs
 Figure 16. Global Hemophilia A Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Hemophilia A Drug Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Hemophilia A Drug Sales (2020-2031) & (K Pcs)
 Figure 19. Global Hemophilia A Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 20. Hemophilia A Drug Report Years Considered
 Figure 21. Hemophilia A Drug Sales Share by Manufacturers in 2024
 Figure 22. Global Hemophilia A Drug Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Hemophilia A Drug Players: Market Share by Revenue in Hemophilia A Drug in 2024
 Figure 24. Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Hemophilia A Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Hemophilia A Drug Sales Market Share by Country (2020-2031)
 Figure 27. North America Hemophilia A Drug Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Hemophilia A Drug Sales Market Share by Country (2020-2031)
 Figure 31. Europe Hemophilia A Drug Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Hemophilia A Drug Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Hemophilia A Drug Revenue Market Share by Region (2020-2031)
 Figure 39. China Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Hemophilia A Drug Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Hemophilia A Drug Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Hemophilia A Drug Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Hemophilia A Drug Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Hemophilia A Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Hemophilia A Drug by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Hemophilia A Drug by Type (2020-2031)
 Figure 61. Global Hemophilia A Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Hemophilia A Drug by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Hemophilia A Drug by Application (2020-2031)
 Figure 64. Global Hemophilia A Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Hemophilia A Drug Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Haemophilia Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bleeding Disorder Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Research Report 2025
Hematological Malignancies Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemorrhagic Shock Treatment Market Research Report 2025
Global Hemoglobinopathies Drugs Market Research Report 2024
Global Anticoagulant Medicine Market Research Report 2025
Sickle Cell Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Global In Vitro Diagnostics IVD Products and Test Market Research Report 2025
Drug Screening Test Kit Market
Global IVD Raw Materials Market Insights Forecast to 2030
Global Hematological Malignancy Treatment Market Research Report 2025
Global Still s Disease Treatment Market Research Report 2025
Global Drugs of Abuse Testing Market Research Report 2024
Global Ant Killer Market Research Report 2024
Global Treatment Planning Software Market Research Report 2025
Hematological Malignancy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs of Abuse Test Kit Market Research Report 2025
Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions